Mesothelin-targeted cd40 agonistic multispecific antibody constructs for the treatment of solid tumors
US-2024150481-A1 · May 9, 2024 · US
This page is not indexed by search engines while we improve data quality.
Egen Jackson patents
Egen Jackson is listed as an inventor on 7 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Egen Jackson |
| Total patents | 7 |
| First publication | Jun 9, 2016 |
| Latest publication | May 9, 2024 |
Notable patents
Publications ranked by popularity score, then publication date.
Mesothelin-targeted CD40 agonistic multispecific antibody constructs for the treatment of solid tumors
US-11926672-B2 · Mar 12, 2024 · US
Combinations of antibody constructs and inhibitors of cytokine release syndrome and uses thereof
US-2023093169-A1 · Mar 23, 2023 · US
Mesothelin-targeted cd40 agonistic multispecific antibody constructs for the treatment of solid tumors
US-2021347905-A1 · Nov 11, 2021 · US
Therapeutic compounds and uses thereof
US-2017333406-A1 · Nov 23, 2017 · US
Therapeutic compounds and uses thereof
US-9763922-B2 · Sep 19, 2017 · US
Therapeutic compounds and uses thereof
US-2016158207-A1 · Jun 9, 2016 · US
Recent patents
Latest publications not already listed above.
No data yet.
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Amgen Inc | 4 |
| Genentech Inc | 3 |
| Constellation Pharmaceuticals Inc | 3 |
| Amgen Res Munch Gmbh | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 7 |
| C07K16/30 | 4 |
| A61K2039/505 | 4 |
| C07K2317/31 | 4 |
| C07K2317/622 | 4 |